Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents

ClinicalTrials.gov ID: NCT00825227

Public ClinicalTrials.gov record NCT00825227. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 6:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents

Study identification

NCT ID
NCT00825227
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cephalon
Industry
Enrollment
10 participants

Conditions and interventions

Interventions

  • Armodafinil 150 mg/day Drug
  • Placebo, Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2008
Primary completion
Sep 30, 2009
Completion
Jan 31, 2010
Last update posted
Nov 16, 2017

2008 – 2010

United States locations

U.S. sites
29
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
Northwest Alabama Cancer Center Muscle Shoals Alabama 35661
Saint Joseph Medical Center Burbank California 91505
Compassionate Cancer Center Fountain Valley California 92708
Wilshire Oncology La Verne California 91750
Compassionate Cancer Center Riverside California 92501
Scripps Cancer Center San Diego California 92123
Washington Cancer Institute Washington D.C. District of Columbia 20010
Integrated Community Oncology Network Jacksonville Florida 32256
Southeastern Gynecologic Oncology, LLC Atlanta Georgia 30342
Augusta Oncology Augusta Georgia 30901
Medical College of Georgia Augusta Georgia 30912
Summit Cancer Center Savannah Georgia 31405
Ingalls Cancer Research Center Harvey Illinois 60426
Iowa Blood and Cancer Care PLC Cedar Rapids Iowa 52402
Center for Cancer and Blood Disorders Bethesda Maryland 20817
Frederick Memorial Hospital Frederick Maryland 21701
Park Nicollet Institute Saint Louis Park Minnesota 55426
Hematology Oncology Centers of the Northern Rockies Billings Montana 59101
Montana Cancer Institute Missoula Montana 59802
Sparta Cancer Center Sparta New Jersey 17871
Forsyth Regional Cancer Center Winton North Carolina 27103
Cancer Care Associates Tulsa Oklahoma 74136
Geisinger Medical Center Danville Pennsylvania 17822
Mount Nittany Medical Center State College Pennsylvania 16803
Chester County Hospital West Chester Pennsylvania 19380
Charleston Hematology Oncology, PA Charleston South Carolina 29403
C. Michael Jones Germantown Tennessee 38138
McLeod Cancer and Blood Center Johnson City Tennessee 37604
Cancer Outreach Assoc. / Outreach Clinical Trial Consortium Abingdon Virginia 24211

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00825227, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 16, 2017 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00825227 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →